Related references
Note: Only part of the references are listed.The effectiveness of intramuscular biperiden in acute akathisia - A double-blind, randomized, placebo-controlled study
Bora Baskak et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2007)
Tardive dyskinesia
Karla Soares-Weiser et al.
SEMINARS IN NEUROLOGY (2007)
Predictors of neuroleptic-induced dyskinesia and parkinsonism - The influence of measurement methods and definitions
Charles E. Dean et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2006)
Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease
Lon S. Schneider et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Parkinsonism and Parkinson's disease in the elderly: A community-based survey in Brazil (the Bambui study)
Maira Tonidandel Barbosa et al.
MOVEMENT DISORDERS (2006)
Low-dose mirtazapine: A new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trial
Michael Poyurovsky et al.
BIOLOGICAL PSYCHIATRY (2006)
Epidemiology of tardive dyskinesia: Is risk declining with modern antipsychotics?
Daniel Tarsy et al.
MOVEMENT DISORDERS (2006)
Efficacy and adverse effects of atypical antipsychotics for dementia: Meta-analysis of randomized, placebo-controlled trials
LS Schneider et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2006)
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
JA Lieberman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Atypical antipsychotics and parkinsonism
PA Rochon et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Antipsychotic medications and drug-induced movement disorders other than Parkinsonism: A population-based cohort study in older adults
PE Lee et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)
Quetiapine in the treatment of focal tardive dystonia induced by other atypical antipsychotics - A report of 2 cases
P Gourzis et al.
CLINICAL NEUROPHARMACOLOGY (2005)
Maintenance treatment of severe tardive dyskinesia with clozapine - 5 years' follow-up
MR Louza et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2005)
Treatment of cervical dystonia with botulinum toxin
J Jankovic
MOVEMENT DISORDERS (2004)
Parkinsonism in a nursing home: Underrecognition
JH Friedman et al.
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2004)
Lower risk for tardive dyskinesia associated with second-generation antipsychotics: A systematic review of 1-year studies
CU Correll et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
The effect of vitamin E treatment on tardive dyskinesia and blood superoxide dismutase: A double-blind placebo-controlled trial
XY Zhang et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2004)
Association of anticholinergic load with impairment of complex attention and memory in schizophrenia
MJ Minzenberg et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Prevalence of neuroleptic-induced movement disorders in chronic schizophrenia inpatients
S Janno et al.
AMERICAN JOURNAL OF PSYCHIATRY (2004)
Half a century of antipsychotics and still a central role for dopamine D2 receptors
S Kapur et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2003)
New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-manalysis
S Leucht et al.
LANCET (2003)
Prevalence of PD and other types of parkinsonism in three elderly populations of central Spain
J Benito-León et al.
MOVEMENT DISORDERS (2003)
Can antipsychotic drugs be classified by their effects on a particular group of dopamine neurons in the brain?
BHC Westerink
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Nithsdale Schizophrenia Surveys 23: movement disorders - 20-year review
J Halliday et al.
BRITISH JOURNAL OF PSYCHIATRY (2002)
Pharmacogenetics of tardive dyskinesia: Combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism
B Lerer et al.
NEUROPSYCHOPHARMACOLOGY (2002)
Effects of newer Antipsychotics on extrapyramidal function
D Tarsy et al.
CNS DRUGS (2002)
Cyproheptadine versus propranolol for the treatment of acute neuroleptic-induced akathisia: A comparative double-blind study
T Fischel et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2001)
Does fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics?:: A new hypothesis
S Kapur et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)
Association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients
DL Liao et al.
NEUROPSYCHOBIOLOGY (2001)
Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis
J Geddes et al.
BRITISH MEDICAL JOURNAL (2000)
Misuse of anticholinergic drugs by people with serious mental illness
N Buhrich et al.
PSYCHIATRIC SERVICES (2000)
Relationship between dopamine D2 occupancy, clinical response, and side effects:: A double-blind PET study of first-episode schizophrenia
S Kapur et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
Share Paper
